Venous Thromboembolism Therapeutic Market Research Report by Drug Class (Direct Thrombin Inhibitors, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Venous Thromboembolism Therapeutic Market is expected to grow from USD 2,045.35 Million in 2020 to USD 2,586.89 Million by the end of 2025.
2. The Global Venous Thromboembolism Therapeutic Market is expected to grow from EUR 1,793.40 Million in 2020 to EUR 2,268.23 Million by the end of 2025.
3. The Global Venous Thromboembolism Therapeutic Market is expected to grow from GBP 1,594.34 Million in 2020 to GBP 2,016.46 Million by the end of 2025.
4. The Global Venous Thromboembolism Therapeutic Market is expected to grow from JPY 218,291.12 Million in 2020 to JPY 276,087.01 Million by the end of 2025.
5. The Global Venous Thromboembolism Therapeutic Market is expected to grow from AUD 2,970.12 Million in 2020 to AUD 3,756.51 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Venous Thromboembolism Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Venous Thromboembolism Therapeutic Market studied across Direct Thrombin Inhibitors, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists.
Based on Geography, the Venous Thromboembolism Therapeutic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Venous Thromboembolism Therapeutic Market including Aspen Pharma, Bayer Healthcare, Bioinvent International, BMS, Boehringer Ingelheim, Daiichi Sankyo, eXlthera Pharmaceuticals, Gamma Therapeutics, Johnson & Johnson, and Sanofi.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Venous Thromboembolism Therapeutic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Venous Thromboembolism Therapeutic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Venous Thromboembolism Therapeutic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Venous Thromboembolism Therapeutic Market?
4. What is the competitive strategic window for opportunities in the Global Venous Thromboembolism Therapeutic Market?
5. What are the technology trends and regulatory frameworks in the Global Venous Thromboembolism Therapeutic Market?
6. What are the modes and strategic moves considered suitable for entering the Global Venous Thromboembolism Therapeutic Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Venous Thromboembolism Therapeutic Market is expected to grow from USD 2,045.35 Million in 2020 to USD 2,586.89 Million by the end of 2025.
2. The Global Venous Thromboembolism Therapeutic Market is expected to grow from EUR 1,793.40 Million in 2020 to EUR 2,268.23 Million by the end of 2025.
3. The Global Venous Thromboembolism Therapeutic Market is expected to grow from GBP 1,594.34 Million in 2020 to GBP 2,016.46 Million by the end of 2025.
4. The Global Venous Thromboembolism Therapeutic Market is expected to grow from JPY 218,291.12 Million in 2020 to JPY 276,087.01 Million by the end of 2025.
5. The Global Venous Thromboembolism Therapeutic Market is expected to grow from AUD 2,970.12 Million in 2020 to AUD 3,756.51 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Venous Thromboembolism Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Venous Thromboembolism Therapeutic Market studied across Direct Thrombin Inhibitors, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists.
Based on Geography, the Venous Thromboembolism Therapeutic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Venous Thromboembolism Therapeutic Market including Aspen Pharma, Bayer Healthcare, Bioinvent International, BMS, Boehringer Ingelheim, Daiichi Sankyo, eXlthera Pharmaceuticals, Gamma Therapeutics, Johnson & Johnson, and Sanofi.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Venous Thromboembolism Therapeutic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Venous Thromboembolism Therapeutic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Venous Thromboembolism Therapeutic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Venous Thromboembolism Therapeutic Market?
4. What is the competitive strategic window for opportunities in the Global Venous Thromboembolism Therapeutic Market?
5. What are the technology trends and regulatory frameworks in the Global Venous Thromboembolism Therapeutic Market?
6. What are the modes and strategic moves considered suitable for entering the Global Venous Thromboembolism Therapeutic Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Direct Thrombin Inhibitors
6.3. Factor XA Inhibitors
6.4. Heparin
6.5. Vitamin K Antagonists
7. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Aspen Pharma
11.2. Bayer Healthcare
11.3. Bioinvent International
11.4. BMS
11.5. Boehringer Ingelheim
11.6. Daiichi Sankyo
11.7. eXlthera Pharmaceuticals
11.8. Gamma Therapeutics
11.9. Johnson & Johnson
11.10. Sanofi
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Direct Thrombin Inhibitors
6.3. Factor XA Inhibitors
6.4. Heparin
6.5. Vitamin K Antagonists
7. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Aspen Pharma
11.2. Bayer Healthcare
11.3. Bioinvent International
11.4. BMS
11.5. Boehringer Ingelheim
11.6. Daiichi Sankyo
11.7. eXlthera Pharmaceuticals
11.8. Gamma Therapeutics
11.9. Johnson & Johnson
11.10. Sanofi
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DIRECT THROMBIN INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY FACTOR XA INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: SCORES
TABLE 41. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RANKING
TABLE 44. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DIRECT THROMBIN INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY FACTOR XA INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: SCORES
TABLE 41. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RANKING
TABLE 44. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DIRECT THROMBIN INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY FACTOR XA INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HEPARIN, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY VITAMIN K ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, BY TYPE
FIGURE 1. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY DIRECT THROMBIN INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY FACTOR XA INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY HEPARIN, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY VITAMIN K ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VENOUS THROMBOEMBOLISM THERAPEUTIC MARKET, BY TYPE
